
Mass General Brigham Ventures
Boston, Massachusetts, United StatesFounded 2008
Mass General Brigham Ventures is an early-stage venture capital firm that invests in life science companies, including digital health, medical devices, diagnostics, and drugs, which emerge from the Mass General Brigham health system's research community. Their strategy involves leveraging this proprietary deal flow and providing strategic support for long-term value creation, primarily at the seed and Series A stages, to develop transformative solutions for unmet medical needs.
83% of their portfolio is in Healthcare. Average disclosed round size is $38.0M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$450M
Top Stage
Seed
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $18.3M | May 2025 | |
| TTuesday Health | Series C | $60M | May 2024 |
| Series A | $57M | Jan 2024 | |
| VViolet Therapeutics | Seed | $10.6M | May 2023 |
| Seed | $32M | Sep 2022 | |
| Series B | $50M | Jan 2022 |
Top Co-Investors
Frist Cressey Ventures2 shared
Ono Venture Investment1 shared
Valtruis1 shared
Blue Venture Fund1 shared
ARCH Venture Partners1 shared
General Catalyst1 shared
GV (Google Ventures)1 shared
F-Prime Capital1 shared
RA Capital Management1 shared
Janus Henderson Investors1 shared
Transformation Capital1 shared
Kaiser Permanente Ventures1 shared
Providence Ventures1 shared
SpringRock Ventures1 shared
UPMC Enterprises1 shared
MemorialCare Innovation Fund1 shared
Memorial Hermann Health System1 shared
Paramark Ventures1 shared
CU Healthcare Innovation Fund1 shared
Last updated: 8 March 2026